New biomarker test – the fifth QIAGEN oncology test with FDA clearance in the U.S. – designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer Germantown, Maryland, and Hilden, Germany, March 29, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of its ipsogen® JAK2 RGQ… Read article →
Since the arrival of personalized healthcare and molecular diagnostics, there has been growing support for utilizing DNA, RNA, and protein-based biomarker detection methods as a means to help reduce rising healthcare costs (1). Molecular diagnostics can help select the right patients for the right treatments, and define which patients require costly confirmatory diagnostic tests. In… Read article →
Kevin de Bruyne just scored the 150th goal of the #WorldCup18 #BRABEL #bra #bel https://t.co/tPpCvvt1ZV, One quarterfinal done, one to go! #bra #bel #BRABEL https://t.co/DLvhrPEcCe, Kick-off for the quarter finals. Who are you rooting for? #uru #fra
Meanwhile we found a new use for #QIAsymphony a… https://t.co/WvVFDMtQwz, Thanks to the organizers, presenters and attendees for making #tts2018 such a great meeting! Need more info about o… https://t.co/OWmTDmpOT5, We'll be at booth 4 til 15:00 to show you our solutions for monitoring immunity and detecting opportunistic pathoge… https://t.co/utPPv5rwFs, 